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Abstract This study investigated whether a novel
ionogenic substance, containing amongst others zinc and
rubidium (PHI-5; Dermagenics Inc, Memphis, TN, USA),
could improve the healing of full-thickness skin wounds.
Uniform wounds were created on the right ﬂank of guinea
pigs. Micro-grooved silicone rubber membranes, contain-
ing 0 (controls), 1.25, 5.00, or 10.00 lg PHI-5, were
sutured onto this wound. Standardized digital wound
photographs were made after 1, 3, and 6 weeks. Also,
wound biopsies were taken after 3 and 6 weeks for histo-
logical and histomorphometrical evaluation. For all study
groups, 6 animals were used. Analysis of the 1-week digital
photographs showed that the surface area of the wounds
decreased signiﬁcantly, with an increasing PHI-5 concen-
tration. No other differences were found in the wound
photographs. Also, no differences were measured in
histomorphometry at 3 and 6 weeks. Concluding, in our
study model a single application of PHI-5 did have a
signiﬁcant positive inﬂuence on initial wound healing.
Introduction
Disturbances in cutaneous wound healing are a major
clinical issue. Especially chronic wounds, like pressure
sores, and diabetic and venous ulcers, are expected to form
a growing problem, because of the ageing of our popula-
tion, and an increase in prevalence of diabetes and level
of disability. Systemic risk factors for developing and
sustaining a chronic wound can be corrected to some
extent. Potential treatments have focused on local aspects,
for instance by wound debridement, pressure regulation,
application of growth factors, the use of (bio-engineered)
skin equivalents, and speciﬁc wound dressings [1]. Despite
present therapeutical options, healing of these wounds
takes much time, effort and money, causing a burden on
national health care.
PHI-5 (Dermagenics Inc, Memphis, TN, USA) is a
novel formulation containing zinc and rubidium ions,
which is developed for treatment of chronic wounds [2].
Commercially, PHI-5 is available as an impregnated
wound dressing material (Dermax ). The ion formula in
PHI-5 is based on analysis of red oak bark extract, a
material traditionally employed for its positive effect on
wound healing. It has been shown that PHI-5 has a positive
inﬂuence on wound healing, when applied in chronic
wounds that were not responding to conventional thera-
peutical interventions [3]. Various authors already
described an imbalance of matrix metalloproteinases
(MMPs), and of MMP inhibitors (TIMPs), in chronic
wound tissue and ﬂuid [4–9]. It is assumed that PHI-5 has
the capability to correct such imbalance between MMPs
and TIMPs. Previously, many studies have shown compa-
rable inhibition of several proteinases by zinc and other
divalent metal ions (copper, cadmium, nickel, calcium)
from a variety of chemical and organic sources [10–17].
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formed on human patients with chronic wounds. To date,
no standardized (animal) experiments have been published
in which the effect of PHI-5 was compared to non-treated
control groups. Therefore, for our current study, the efﬁ-
cacy of PHI-5 in a standardized animal model was inves-
tigated. Also, different concentrations have to be regarded,
as no optimal dose for PHI-5 has been described yet. We
hypothesize that microtextured silicone wound covers
loaded with PHI-5 can improve wound healing, when
placed in a standardized full-thickness skin wound in vivo.
Guinea pigs were selected as the experimental animal
based on their skin structure, which is close to human skin
[18]. The efﬁcacy of the study design was already proven
in an earlier comparable study [19].
Materials and methods
Substrates with PHI-5
Medical-grade silicone rubber (polydimethylsiloxane,
NuSil MED-4211, NuSil Technology, CA, USA) was
mixed as prescribed. To obtain a single-sided microtexture,
the mixture was cast on a silicon template, containing
micro-grooves with a groove depth of 1.0 lm and a ridge-
and groove-width of 10.0 lm (C2V, Enschede, the
Netherlands). After polymerisation, coin-shaped substrates
of 20 mm diameter were cut from the produced sheets.
Substrates were washed in 10% liquinox solution
(Alconox, New York, NY, USA), cleaned ultrasonically,
and rinsed thoroughly in reverse osmosis water (MilliQ,
Millipore Corp, Bedford, MA, USA). Subsequently, they
were washed in 70% and 100% ethanol and dried to air.
The membranes were autoclaved for sterilisation at 121  C
for 15 min. A radio frequency glow discharge (RFGD;
Argon, 5 min) treatment was applied to remove surface
fouling, and to hydrophilize the textured side. Finally, the
membranes were loaded with aliquots of equal volume,
containing 0, (controls), 1.25, 5.00 and 10.00 lg of PHI-5,
and lyophilized overnight.
Animals
The study protocol was approved by our University Animal
Ethics Committee, all experiments were carried out
according to the Dutch Experiments on Animal Act, and
under appropriate licenses. Speciﬁed pathogen-free male
young adult albino Hartley-derived guinea pigs were used,
weighing approximately 620 g. The animals were housed
individually, and received chow and water ad libitum. For
each study group per time period 6 guinea pigs were used.
Each animal had one wound on its right ﬂank, covered with
one of the silicone membranes.
Application procedure
Pre-operatively, the animals were shaved thoroughly.
Surgery was performed under general inhalation anes-
thesia of O2,N 2O, and isoﬂurane. Prior to creating the
wound, local anesthesia was given by inﬁltration with
lidocain 2% including adrenalin. The skin was scrubbed
with iodine, and subsequently, standardized orientation
points to measure wound contraction were created with
tattooing ink, using ﬁxed holes in a pre-made steel mold.
The center of this mold contained a 20 mm Ø circular
hole, used to mark the amount of tissue to be excised
(Fig. 1A). Then, the circular full-thickness cutaneous
wounds extending to the panniculus carnosus were cre-
ated on the right ﬂank of each guinea pig, using aseptic
techniques. The silicone substrates were sutured onto the
wound, with the side containing PHI-5 making contact
with the wound (Fig. 1C). Subsequently, wounds were
covered with semi-permeable polyurethane dressings
(Tegaderm, 3M Co, Minneapolis, Mn, USA). One layer of
dry sterile ﬁne mesh gauze (Tendra Mesoft 5 · 5 cm,
Mo ¨lnlycke, Go ¨teborg, Sweden) was applied onto the
Tegaderm, and the dressings were secured in place with
two circular layers of surgical tape (Elastoplast-E 6 cm,
Beiersdorf, Spain). Special attention was paid to the
design of the bandage. The outer layer of tape was also
wrapped in front of the fore legs, thus preventing the
guinea pigs to remove it by paw movement or chewing
(Fig. 1D). After 1 week, the PHI-5 containing silicone
membranes were removed. Thereafter, the bandages were
reapplied.
After 3 or 6 weeks, animals were sacriﬁced by intra-
cardial injection of a lethal dose of pentobarbital, after
which the wound and all surrounding tissues were retrieved
for histological and histomorphometrical analyses.
Morphometrical evaluation of the wounds
The method of evaluation was adapted from our previous
publication [19]. Standardized digital wound photographs
were taken on days 7, 21 and 42, using a digital camera
on macro setting. Photographs were calibrated to distance
with a ruler on each photograph, using Leica Qwin
software (Leica Microsystems Imaging Solutions, Ltd,
UK). Per photograph, two measurements were made
(Fig. 2A–C); Wound Surface Area (WSA) and Reference
Surface Area (RSA). These indicate the amount of
wound closure, and the amount of wound contraction
respectively.
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After retrieval, the excised tissue was ﬁxed in 4% buffered
formaldehyde for 24 h, dehydrated in a series of ethanol,
and embedded in parafﬁn. Thereafter, 6 lm sections were
cut using a Leica RM 2165 Microtome. Every 25th section
was collected and stained with haematoxilin and eosin
(Merck, Darmstadt, Germany).
Histomorphometry
Computer-based image analysis of re-epithelialisation,
wound area, and granulation tissue was performed on
histological images. Per wound three histology sections,
150 lm apart, were selected for evaluation. In the
3-week sections, three parameters were measured at
pre-determined locations in the wound: length of the
neo-epithelial layer, size of wound opening, and
narrowest width of the granulation core (Fig. 3). In the
6-week sections, measurements were made in three layers
of the superﬁcial granulation tissue, thereafter calculating
the mean length of the superﬁcial granulation tissue.
Also, the narrowest distance between hair follicles (rep-
resenting the edges of the original skin tissue) on either
side of the originally excised wound tissue, was mea-
sured (Fig. 4).
Fig. 1 Surgical procedure. (A)
The surgical area was drawn
onto the skin using a pre-
fabricated steel mold. (B)
Anaesthetized guinea pig with
drawing on right ﬂank. (C)
Circular wound, 2 cm Ø, after
application of the silicone
membrane. (D) Application of
bandage
Fig. 2 Morphometrical
analysis of a wound at day 7 (A)
Wound, with calibration ruler.
(B) Wound Surface Area
(WSA). (C) Reference Surface
Area (RSA)
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The averages and standard deviations of data from the
quantitative measurements were calculated. Then, data
were compared with a one-way ANOVA and a Tukey
post-hoc test, using InStat software (v3.05, GraphPad
InStat software, GraphPad Inc.). A P value below 0.05 was
considered to be signiﬁcant.
Results
Clinical observation
One guinea pig in the high concentration study group died
day one post-operative of unknown cause. All other ani-
mals remained in good health throughout the experiment,
and no wound infections were observed. Only three guinea
pigs managed to remove the bandage before the end of the
study period.
After 1 week, in all groups it was observed that the
wounds had not closed yet. After 3 weeks, the wounds
were nearly closed or closed. After 6 weeks, all wounds
were fully closed, resulting in an elongated scar, directed
cranio-caudally (Fig. 5A–D). One of the animals showed
wound closure in a dorsoventral direction. Therefore, this
animal was excluded from histomorphometrical measure-
ments.
Wound photographs
After 1 week, signiﬁcant differences between study groups
were measured for the WSA. Here, the control animals still
had the largest wounds. Increase of the concentration of
PHI-5 resulted in a decrease of the wound size. This dif-
ference was signiﬁcant as tested by ANOVA. Tukey’s post
hoc test revealed a signiﬁcant difference between the
control group and the high concentration group. However,
after 3 weeks, this difference was not found to persist.
After 6 weeks, all wounds were closed, so that the WSA
could not be measured (Fig. 6).
For measurement of the RSA, one animal of the low
concentration group was excluded because of doubtful
tattoo markings. In all experimental groups, the RSA could
be found to expand (Fig. 7) over the study period. No
signiﬁcant differences between groups could be found on
any experimental period measured.
Histology
Three weeks after surgery, the excised skin was replaced
by a varying amount of granulation tissue, consisting of
ﬁbrinoid material and inﬂammatory cells (Fig. 8A–B,
9A–B). Of all excised wounds, two seemed still to have an
intact panniculus carnosus. Re-epithelialisation was ob-
served over the woundbed area, although only ﬁve wounds
(all in the control and low concentration groups) were fully
covered by an intact epithelium, containing a recognisable
basal cell layer. When a defect of epithelial lining was still
present, many superﬁcial capillaries were seen, as well as
thickening of the epithelium at the wound edges.
In all sections of the 6-week specimens, an intact
keratinizing squamous epithelial lining was seen, which in
some cases showed the start of rete peg formation
(Fig. 10). Just below the epithelium, a varying amount of
granulation tissue was present, becoming narrower at the
level of the hair follicles and connective tissue. Even
deeper in the sections, a broad area of granulation tissue
was always predominantly present, in between both sides
of the pre-existent panniculus carnosus.
Fig. 3 Histomorphometrical measurements on a histological section,
3 weeks after surgery. A = length of neo-epithelium B = wound
opening, C = width of granulation tissue ED = epidermis, HF = hair
follicle, CT = connective tissue, GT = granulation tissue,
PC = panniculus carnosus,P A=panniculus adiposus
Fig. 4 Histomorphometrical measurements on a histological section,
6 weeks after surgery. Length of superﬁcial granulation tissue is
measured at three levels (A, B, C), as well as the narrowest distance
between hair follicles (D)
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After 3 weeks, no signiﬁcant differences were found
among the experimental groups for the length of the wound
opening, neo-epithelium, or granulation tissue (Table 1).
Also, in the 6-week groups, no signiﬁcant differences in
length of the superﬁcial granulation tissue or distance be-
tween hair follicles were found (Table 2).
Discussion
An in vivo study was performed on the effect of PHI-5 on
cutaneous wound healing in a guinea pig model. First, a
standardized wound was created. Results showed a faster
wound closure after 1 week, when 10.00 lg of PHI-5 was
applied. After 3 and 6 weeks however, no differences
among study groups were found in any of the measure-
ments.
Several remarks can be made about the study set-up.
Guinea pigs were used, as these are a common animal
model in research on cutaneous wound healing [18–25].
Although their skin structure is reported to be similar to
human skin [18], some apparent differences still exist.
Guinea pigs are loose-skinned, have a dense layer of body
hair, a thin epidermis and dermis, a low amount of sub-
cutaneous fat and their skin structure contains a panniculus
carnosus [18, 26]. Sullivan et al. state wound healing in
such animals to be primary due to contraction. Therefore it
will be deﬁnitely different from human cutaneous healing,
where both re-epithelialisation and contraction play an
Fig. 5 Wound appearance. (A)
Day 7, all wounds are still open.
(B, C) Day 21, wounds are
either (B) nearly or (C) fully
closed. (D) Day 42, all wounds
are closed, producing a linear
craniocaudal scar
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Fig. 6 Mean Wound Surface Area (WSA). Note that on day 7, with
an increasing concentration of PHI-5, the wound surface was
signiﬁcantly smaller. Bars indicate SD
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Fig. 7 Mean Reference Surface Area (RSA). In all groups, the RSA
signiﬁcantly expands over the days. Note also the trend of a smaller
RSA with an increasing concentration of PHI-5 on day 7. These
differences resemble those of the WSA, although here are not
signiﬁcant. Bars indicate SD
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workers found no inﬂuence of looseness of skin on wound
healing mechanisms [27]. In our study, we observed that
re-epithelialisation occured in the guinea pigs after
3 weeks. After 6 weeks of healing, the edges of the ori-
ginal skin tissue (containing hair follicles) were lying
approximate to each other. This might indicate that even-
tual wound closure in guinea pig skin is due to contraction,
and re-epithelialisation has just a temporary role in
covering the original defect.
Besides the wound healing process, four other remarks
should be made about the animal model. First, ﬁnding a
bandage method for guinea pigs, which can stay secure for
several weeks, has been challenging. With the method we
applied here only three animals managed to remove their
bandage. This very high success rate corroborates our
earlier study [19]. Second, in efforts to minimize the use of
laboratory animals, we adapted the study design from a
previous study [19] where animals were sacriﬁced, and
histology was processed at week 3 and 6. No wound tissue
was retrieved 1 week after surgery. In hindsight, this was
an unfortunate decision since PHI-5 did exhibit an effect at
week 1. Third, the ‘Reference Surface Area’ is a parameter
often used in measuring wound contraction. In this study,
all areas increased throughout the experiment in each study
group. Most probably, this parameter merely reﬂects the
weight gain of the animals. For this reason, we conclude
this measurement not to be appropriate for describing
wound contraction in the experimental model. Finally, we
Fig. 8 Histological section, HE staining, 3 weeks after surgery. (A)
A large epithelial defect is still present. (B) Higher magniﬁcation,
note that the basal cell layer is deﬁcient over the woundbed area
Fig. 9 Histological section, HE staining, 3 weeks after surgery. (A)
The whole surgical wound area is covered by a new layer of
epithelium (B) Higher magniﬁcation, note that the new epithelial
layer contains an intact layer of basal cells
Fig. 10 Histological sections, HE staining, 6 weeks after surgery.
(A) and (B) All sections are fully covered with epithelium, but
contain varying amounts of granulation tissue
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123have used an acute excisional wound model, although
PHI-5 has originally been developed for treatment of
chronic wounds. The rationale for this is that a chronic
wound is uncommon in animals, and extraordinary
measures (creating ischemia, denervation or diabetes) are
required to attempt to reproduce authentic lesions in an
animal model [28]. Moreover, all models still differ
from human chronic wounds, which most often are multi-
factorial.
Like with the animal model, a speciﬁc annotation has to
be made on the use of our delivery vehicle of PHI-5 into
the wound area. It might be suggested, that suturing a sil-
icone membrane onto the wound could serve as a stent
keeping the wound open, and preventing wound contrac-
tion in the ﬁrst week post operative. However, in a previous
study no differences were seen between the control group
wearing a silicone membrane, and a sham group having the
wound left open [19].
Considering the measurements, after 1 week all wound
photographs showed a decrease in WSA, for the higher
PHI-5 concentrations. Especially, signiﬁcant differences
were found between the control group and the highest con-
centrationgroup.Thismeans,atleastpartially,thehypothesis
can be maintained that microtextured polymeric mem-
branes loaded with PHI-5 can improve wound healing, when
placed in a full-thickness cutaneous wound in vivo. How-
ever, two weeks post operative, no signiﬁcant differences
between groups could be measured anymore. One plausible
explanation for ﬁnding only short-term effects seems to be
related to the release pattern of PHI-5. Earlier study results
have shown that proteinaceous growth factors are released
from microtextured surfaces, within 24 h in a burst-like
manner [29]. Being a water-soluble ionic solution, PHI-5 is
probably released even faster than proteins. In fact, clini-
cians usually are re-applying PHI-5-containing bandages
daily.Thus,follow-upstudiesintheanimal modelshouldbe
designed to deliver multiple doses, or make use of an
appropriate slow-release system. Next to the delivery mode,
the efﬁcacy of PHI-5 could also be dependent on the dose.
The greatest effect of PHI-5 was measured, when the high
concentration of 10.00 lg per wound was used. Even higher
concentrations would have to be tested, to ﬁnd the optimum
level for treatment.
The ﬁrst scope of this study was to prove that PHI-5 is
effective in a standardized animal model. Although the
underlying working mechanism of PHI-5 was not investi-
gated, some knowledge exists on this subject. The
expression of MMP-2 is higher in chronic wounds than in
acute wounds [10, 14], and the role of MMP-2 in
non-healing wounds is thought to be a pathological one [1,
4–7]. Previous literature postulates that PHI-5 corrects an
imbalance of MMPs in the wound area, by lowering the
release of MMP-2. On the contrary, other researchers also
suggest a pivotal physiological role for MMP-2 in the
re-epithelialisation of acute human wounds [30]. Down-
regulation of MMP-2 by PHI-5 has been stated based on
biopsies from wounds treated with Dermax  [3]. The
mechanism of inhibition is unknown, but might be a direct
effect of PHI-5 on MMP-2 activity. Possibly, the metal
ions in PHI-5 bind to the active part of the protease, pre-
venting the enzyme to bind to its substrate. Alternatively,
the ions could cause conformational changes, thereby
lowering the catalytic function of the enzyme [17]. How-
ever, inhibition of MMP-2 can also theoretically be an
indirect effect of PHI-5, due to a naturally occurring
concentration decline of MMP-2 throughout the healing
process.
Alternative working mechanisms have been stated by
van den Berg et al. They showed that PHI-5 inhibited
complement activation, and the production of reactive
oxygen species by polymorphonuclear neutrophils. Both of
these factors could also be contributing factors in the
positive effect of PHI-5 on wound healing [31].
Conclusion
Concluding, we can say that PHI-5 has a positive inﬂuence
on early cutaneous wound healing in a standardized animal
model. The results seem to justify further studies using
Table 1 Average histomorphometrical measurements and standard
deviations after 3 weeks (mm)
Control
(SD)
Low
(SD)
Medium
(SD)
High
(SD)
Epithelial defect 1.20 (1.64) 1.17
(1.61)
2.29 (1.96) 2.99
(1.09)
Granulation core
width
2.48 (1.02) 3.18
(1.51)
2.85 (0.72) 2.60
(1.09)
Neo-epithelial
length
4.94 (2.06) 5.48
(2.25)
5.99 (1.68) 5.51
(1.72)
No signiﬁcant differences between different concentration groups
were found in width of epithelial defect, granulation core width, or
length of neo-epithelium
Table 2 Average histomorphometrical measurements and standard
deviations after 6 weeks (mm)
Low (SD) Medium (SD) High (SD)
Granulation width 1.57 (0.46) 0.84 (0.66) 1.19 (0.54)
Follicle distance 1.35 (0.87) 0.59 (0.54) 0.60 (0.46)
No signiﬁcant differences between different concentration groups
were found in width of superﬁcial granulation tissue or in narrowest
follicle distance among groups
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123higher doses and sustained release systems loaded with
PHI-5, and on elucidating its working mechanism.
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